Skip to main content
Log in

Thyroid hormone autoantibodies in primary Sjögren syndrome and rheumatoid arthritis are more prevalent than in autoimmune thyroid disease, becoming progressively more frequent in these diseases

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

An Erratum to this article was published on 01 July 2002

Abstract

To verify the greater prevalence of circulating thyroid hormone autoantibodies (THAb) in primary Sjögren syndrome (SS) vs Hashimoto’s thyroiditis (HT) and Graves’ disease (GD), we measured THAb in the serum of patients with these 3 diseases who were sampled from 1998–1999 (no.=20, 88, 25) and 1990–1992 (no.=13, 75, 31). Patients with rheumatoid arthritis (RA) (no.=23 and 16) and other collagenoses (no.=20 and 16) were also studied. A third series of patients with these 5 diseases was studied from 1975–1982, and data have been taken into account. THAb were detected using a specific radioimmunoprecipitation method, and their presence was correlated with the presence of TG antibodies (TGAb). We found that IgG antibodies against T3, T4 or both were present with these pre-valences in the 1975–1982, 1990–1992 and 1998–1999 series: HT=1, 4, 20%; GD=2, 6, 32%; SS=20, 31, 50%; RA=0, 12, 26%; other collagenoses=0, 0, 0%. The majority of the Sjögren or arthritis cases positive for THAb were negative for TGAb, while the opposite was true for the 2 autoimmune thyroid diseases. We conclude that prevalence of THAb in the 2 non-thyroid autoimmune diseases is greater than in the 2 thyroid autoimmune diseases. In addition, prevalence of THAb is increasing over time regardless of disease. Molecular similarity between extra-thyroid connective proteins (specifically associated to primary SS and RA) and iodinated regions of TG, and an increased preponderance of environmental factors as triggers of autoimmune diseases might account for our findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Benvenga S., Trimarchi F., Robbins J. Circulating thyroid autoantibodies. J. Endocrinol. Invest. 1987, 10: 605–619.

    CAS  PubMed  Google Scholar 

  2. Elsing C., Pilar K., Hehrmann R. Haufgeikt und Klinische Bedeutung Zirkkiliender Autoantikorper gegen Schildrussenhormone. Akt. Endokr. Stoffw. 1991, 12: 49–56.

    Google Scholar 

  3. Larsen P.R., Davies T.F., Hay I.D. The thyroid gland. In: Wilson J.D., Foster D.W., Kronenberg H.M., Larsen P.R. (Eds.), Williams Textbook of Endocrinology. W.B. Saunders, Philadelphia, 1998, p. 389.

    Google Scholar 

  4. Trimarchi F., Benvenga S., Costante G., et al. Identification and characterization of circulating thyroid hormone autoantibodies in thyroid diseases, in autoimmune non-thyroid illnesses and in lymphoreticular disorders. J. Endocrinol. Invest. 1983, 6: 203–209.

    CAS  PubMed  Google Scholar 

  5. Perez E.B., Kraus A., Lopez G., Cifuentes M., Alarcon-Segovia D. Autoimmune thyroid diseases in primary Sjögren syndrome. Am. J. Med. 1995, 99: 480–484.

    Article  CAS  PubMed  Google Scholar 

  6. Benvenga S., Bartolone L., Squadrito S., Trimarchi F. Thyroid hormone autoantibodies elicited by diagnostic fine-needle biopsy. J. Clin. Endocrinol. Metab. 1997, 82: 4217–4223.

    CAS  PubMed  Google Scholar 

  7. Vitali C., Bombardieri S., Moutsopoulos H.M., et al. for the European Community Study Group on the Diagnostic Criteria for Sjögren sindrome. Preliminary criteria for the classification of Sjögren syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 1993, 36: 340–347.

    Article  CAS  PubMed  Google Scholar 

  8. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980, 23: 581–590.

    Article  Google Scholar 

  9. Bohan A., Peter J.B. Polymiositis and dermatomyiositis. Part I and part II. N. Engl. J. Med. 1975, 292: 344–403.

    Article  CAS  PubMed  Google Scholar 

  10. Weetman A.P. Chronic autoimmune thyroiditis. In: Bravermann L.E., Utiger R.D. (Eds.), Werner and Ingbar’s The Thyroid. Lippincott-Raven, Philadelphia, 1996, p. 738.

    Google Scholar 

  11. Komaki T., Sakata S., Nakamura S., Kamiko K., Miura K. Two cases associated with thyroid hormone autoantibodies. In: Walfish P.G., Wall J.R., Volpe R. (Eds.), Autoimmunity and the thyroid. Academic Press, Orlando, 1985, p. 403.

    Chapter  Google Scholar 

  12. Lipsky P.E. Artrite reumatoide. In: Isselbacher K.J., Braunwald E., Wilson J.D., Martin J.B., Fauci A.S., Kasper D.L. (Eds.), Harrison Principi di Medicina Interna. McGraw-Hill, Milan, 1995, p. 1868.

    Google Scholar 

  13. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315–324.

    Article  CAS  PubMed  Google Scholar 

  14. Tan E.M., Cohen A.S., Fries J.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25: 1271–1277.

    Article  CAS  PubMed  Google Scholar 

  15. Moutsopoulos H.M. Sindrome di Sjögren. In: Isselbacher K.J., Braunwald E., Wilson J.D., Martin J.B., Fauci A.S., Kasper D.L. (Eds.), Harrison Principi di Medicina Interna. McGraw-Hill, Milan, 1995, p. 1885.

    Google Scholar 

  16. Fye K.H., Sack K.E. Rheumatic diseases. In: Stites D.P., Stobo J.D., Fudenberg H.H., Wells J.V. (Eds.), Basic and Clinical Immunology. Lange Medical Publications, Los Altos, 1982, p. 423.

    Google Scholar 

  17. Dunn J.T., Dunn A.D. Thyroglobulin: chemistry, biosynthesis and proteolysis. In: Bravermann L.E., Utiger R.D. (Eds.), Werner and Ingbar’s The Thyroid. Lippincott-Raven, Philadelphia, 1996, p. 90.

    Google Scholar 

  18. Kuppers R.C., Bresler H.S., Burek C.L., Gleason S.L., Rose N.R. Immunodominant determinants of thyroglobulin-associated with autoimmune thyroiditis. In: Bona C.A., Kaushick A.K. (Eds.), Molecular immunobiology of self-reactivity. Marcel Dekker, New York, 1992, p. 247.

    Google Scholar 

  19. Martin D.W. Jr. Glycoproteins, proteoglycans and glycosaminoglycans. In: Martin D.W. Jr, Mayes P.A., Rodwell D.W., Granner D.K. (Eds.), Harper’s review of Biochemistry. Lange Medical Publications, Los Altos, 1985, p. 464.

    Google Scholar 

  20. Brucker-Davis F. Effects of environmental synthetic chemicals on thyroid function. Thyroid 1998, 8: 827–856.

    Article  CAS  PubMed  Google Scholar 

  21. Rasmussen A.K., Hartoft-Nielsen M.L., Feldt-Rasmussen U. Models to study the pathogenesis of thyroid autoimmunity. Biochimie 1999, 81: 511–515.

    Article  CAS  Google Scholar 

  22. Rhodus N.L. Sjögren’s syndrome. Quintessence Intl. 1999, 30: 689–699.

    CAS  Google Scholar 

  23. Danieli G., Gabrielli A., Pomponio G. Etiologia e patogenesi dell’artrite reumatoide. In: Dammacco F., Danieli G. (Eds.), Clinica Immunologica. Il Pensiero Scientifico, Roma, 1997, p. 189.

    Google Scholar 

  24. Benvenga S., Ruggeri R.M., Lapa D., Russo A., Campenni A., Trimarchi F. The current presentation of Hashimoto’s thyroiditis is different from that of the 1970’s. 12th International Thyroid Congress, Kyoto (Japan), October 22–27, 2000. Endocr. J. 2000, 47 (Abstract: 192 P-345/D) (Suppl.): 192.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Benvenga.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/BF03345072.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ruggeri, R.M., Galletti, M., Mandolfino, M.G. et al. Thyroid hormone autoantibodies in primary Sjögren syndrome and rheumatoid arthritis are more prevalent than in autoimmune thyroid disease, becoming progressively more frequent in these diseases. J Endocrinol Invest 25, 447–454 (2002). https://doi.org/10.1007/BF03344036

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03344036

Key-words

Navigation